"Governor Newsom announced that California’s CalRx® Insulin Glargine in pen form will be available to consumers for a suggested retail price of not more than $55 per five-pack of pens (average cost of $11 per pen) beginning January 1, 2026, reducing barriers to accessing this essential diabetes medication."
